← SynDRA
PF-04620110
SynDRA canonical compound SYN0027878 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | DGAT1 |
|---|
| Mechanism of action | Diacylglycerol O acyltransferase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Diacylglycerol O acyltransferase inhibitor
- DGAT1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- PF-4620110
- CHEMBL1835919
- 2-(trans-4-(4-(4-Amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl)cyclohexyl)acetic acid
- trans-4-[4-(4-Amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexaneacetic acid
- 2-(trans-4-(4-(4-Amino-5-oxo-7,8-dihydropyrimido[5,4-f]-[1,4]oxazepin-6(5H)-yl)phenyl)cyclohexyl)acetic acid
- UNII-CQ4M18RLJW
- CQ4M18RLJW
- SCHEMBL1424362
- SCHEMBL1425038
- GTPL7829
- SCHEMBL1424359
- SCHEMBL13954265
- DTXSID90677361
- GEVVQZHMFVFGLN-HDJSIYSDSA-N
- DB-120776
- HMS3745K05
- EX-A10681
- s7192
- HMS3870M13
- F83814
- SB19585
- GLXC-10892
- AKOS016011621
- MFCD19443642
- NCGC00356837-06
- EBC-498114
- NCGC00389511-01
- HMS3653O15
- T6937
- BDBM50355142
- BRD-K30550578-001-01-3
- SW220213-1
- CS-0370
- MS-26684
- PF-04620110, >=98% (HPLC)
- orb1685535
- CCG-268606
- HY-13009
Look up PF-04620110 in the interactive SynDRA portal →